Chikungunya Fever – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions.
Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal anti-inflammatory drugs (NSAIDs).
The Chikungunya Fever drugs in development market research report provide comprehensive information on the therapeutics under development for Chikungunya Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Chikungunya Fever | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 53 molecules, with 39 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Chikungunya Fever therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Chikungunya Fever pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Chikungunya Fever treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Access to Advanced Health InstituteActivirosomes Ltd
Auro Vaccines LLC
Bavarian Nordic AS
Bharat Biotech Ltd
BioNet-Asia Co Ltd
Bow Therapeutics
Ciloa
Clayton Biotechnologies Inc
Collaborations Pharmaceuticals Inc
Defender Pharmaceuticals Inc
Duke University
Dultech Advanced Sciences
Emergex Vaccines Holding Ltd
Ennaid Therapeutics LLC
Griffith University
Hawaii Biotech Inc
ImmunityBio Inc
Imophoron Ltd
Indian Immunologicals Ltd
Inovio Pharmaceuticals Inc
Integral Molecular Inc
Integrated BioTherapeutics Inc
Medigen Inc
Meletios Therapeutics SAS
Merck & Co Inc
Najit Technologies Inc
National University of Singapore
Pai Life Sciences Inc
Paradigm Biopharmaceuticals Ltd
Pasteur Institute
Precision Virologics Inc
ProtInhi BV
RedHill Biopharma Ltd
Riboscience LLC
Sementis Ltd
Singapore Immunology Network
Takeda Pharmaceutical Co Ltd
Technovalia Pty Ltd
University of Naples
University of Oxford
University of Surrey
University of Texas Medical Branch at Galveston
Valneva SE
Vanderbilt University
Vaxart Inc
VenatoRx Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Chikungunya Fever reports